The Global Health Body Raises Warning Over Acute Shortage of Obesity Medications
Less than a tenth of people who could benefit from GLP-1 drugs including Wegovy are able to get them, states the World Health Organization as it issues its first guidance on the medications.
Given in excess of 1,000,000,000 people worldwide now obese, it is calling for increased and just access to these injectable treatments.
Based on estimates, over two billion will be living with obesity by 2030 unless action is taken.
"Our latest guidance affirms that obesity is a lifelong illness that can be treated with comprehensive and lifelong support," remarked its chief Tedros Adhanom Ghebreyesus.
Substantial prices, constrained manufacturing, and distribution challenges are major hurdles to broad availability to the treatments that can aid individuals in losing significant body mass, says the organization.
Weight-Loss Drug Supply Crisis
Even under the current most favorable scenario, the production of GLP-1 therapies might only reach approximately 100 million people – fewer than 10% of eligible patients, according to the health organization.
The recommendation urges nations and manufacturers to widen access, via measures such as licensing agreements.
The intellectual property rights on a key compound – the core ingredient of a leading brand – is scheduled to end in multiple countries in 2026.
The Way Obesity Drugs Operate
These medications imitate a biological compound to slow digestion, curb appetite and increase feelings of fullness so people reduce food intake.
People commonly start to lose weight within a few weeks of commencing the weekly injections.
Evidence indicates people may see weight return a year later of halting the drug, because their usual food cravings come back.
To be overweight or obese elevates your chance for experiencing health problems, like diabetes, cardiovascular issues, brain attack, and certain cancers.
Excess weight affects individuals in countries worldwide and was associated with over three and a half million fatalities worldwide in 2024, as per the health agency.